• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ADAPT and Improvise: Overcoming Bacillus Calmette-Guérin Unresponsiveness in Non-muscle-invasive Bladder Cancer.

作者信息

Maitre Priyamvada, Sangar Vijay, Choudhury Ananya

机构信息

Department of Clinical Oncology, The Christie NHS Foundation Trust, University of Manchester, Manchester, UK.

Department of Uro-Oncology, The Christie NHS Foundation Trust, University of Manchester, Manchester, UK.

出版信息

Eur Urol. 2023 Jun;83(6):495-496. doi: 10.1016/j.eururo.2023.02.018. Epub 2023 Mar 9.

DOI:10.1016/j.eururo.2023.02.018
PMID:36898871
Abstract
摘要

相似文献

1
ADAPT and Improvise: Overcoming Bacillus Calmette-Guérin Unresponsiveness in Non-muscle-invasive Bladder Cancer.适应与即兴发挥：克服非肌层浸润性膀胱癌中卡介苗无反应性
Eur Urol. 2023 Jun;83(6):495-496. doi: 10.1016/j.eururo.2023.02.018. Epub 2023 Mar 9.
2
Bacillus Calmette-Guérin (BCG) unresponsive non-muscle-invasive bladder cancer: are the subgroups equal?卡介苗（BCG）无反应的非肌层浸润性膀胱癌：各亚组相同吗？
BJU Int. 2023 Oct;132(4):384-386. doi: 10.1111/bju.16087. Epub 2023 Jun 15.
3
A 23-Gene Prognostic Index Predicts Progression and Bacillus Calmette-Guérin Response in Non-muscle-invasive Bladder Cancer.一种23基因预后指数可预测非肌层浸润性膀胱癌的进展及卡介苗反应。
Eur Urol. 2024 Apr;85(4):400-402. doi: 10.1016/j.eururo.2024.01.001. Epub 2024 Jan 11.
4
SWOG S1605: Moving Beyond Systemic Immune Checkpoint Inhibitor Monotherapy in Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder Cancer.SWOG S1605：超越卡介苗无反应性非肌层浸润性膀胱癌的全身免疫检查点抑制剂单一疗法
Eur Urol. 2023 Dec;84(6):545-546. doi: 10.1016/j.eururo.2023.09.013. Epub 2023 Oct 4.
5
A Step Closer to Predicting Progression After Bacillus Calmette-Guérin Immunotherapy in High-risk Non-muscle-invasive Bladder Cancer.在高危非肌肉浸润性膀胱癌的卡介苗免疫治疗后，预测进展又迈进了一步。
Eur Urol. 2023 Nov;84(5):447-448. doi: 10.1016/j.eururo.2023.06.017. Epub 2023 Jul 1.
6
Association of Increased Age With Decreased Response to Intravesical Instillation of Bacille Calmette-Guerin in Patients With High-Risk Non-Muscle Invasive Bladder Cancer: Retrospective Multi-Institute Results From the Japanese Urological Oncology Research Group JUOG-UC- 1901-BCG.高危非肌层浸润性膀胱癌患者年龄增加与卡介苗膀胱灌注反应降低的相关性：日本泌尿外科肿瘤学研究组JUOG-UC-1901-BCG的回顾性多机构研究结果
Urology. 2023 Mar;173:229. doi: 10.1016/j.urology.2022.10.031. Epub 2022 Dec 30.
7
Evaluating the cost-utility of intravesical Bacillus Calmette-Guérin versus radical cystectomy in patients with high-risk non-muscle-invasive bladder cancer in the UK.评估卡介苗膀胱灌注与根治性膀胱切除术对英国高危非肌层浸润性膀胱癌患者的成本效益。
J Med Econ. 2023 Jan-Dec;26(1):411-421. doi: 10.1080/13696998.2023.2189860.
8
Predictive biomarkers of response to bacillus Calmette-Guérin immunotherapy and bacillus Calmette-Guérin failure for non-muscle invasive bladder cancer.预测卡介苗免疫治疗和卡介苗失败对非肌肉浸润性膀胱癌反应的生物标志物。
Int J Urol. 2022 Aug;29(8):807-815. doi: 10.1111/iju.14921. Epub 2022 May 22.
9
Insignificant role of bacillus Calmette-Guérin maintenance therapy after complete transurethral resection of bladder tumor for intermediate- and high-risk non-muscle-invasive bladder cancer: Results from a randomized trial.卡介苗维持治疗在中高危非肌层浸润性膀胱癌经尿道膀胱肿瘤完全切除术后的作用不显著：一项随机试验的结果
Int J Urol. 2016 Oct;23(10):854-860. doi: 10.1111/iju.13167. Epub 2016 Jul 15.
10
Biology of BCG response in non-muscle invasive bladder cancer - 2021 IBCN Updates Part III.非肌层浸润性膀胱癌中 BCG 反应的生物学特性 - 2021 IBCN 更新第三部分。
Urol Oncol. 2023 May;41(5):211-218. doi: 10.1016/j.urolonc.2022.09.012. Epub 2022 Oct 18.

引用本文的文献

1
The Promise of Radiotherapy in High-Risk Non-Muscle Invasive Bladder Cancer.放疗在高危非肌层浸润性膀胱癌中的前景
Cancers (Basel). 2025 Feb 13;17(4):628. doi: 10.3390/cancers17040628.
2
Radiotherapy in metastatic bladder cancer.转移性膀胱癌的放射治疗。
World J Urol. 2024 Jan 20;42(1):47. doi: 10.1007/s00345-023-04744-x.